FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics (NASDAQ: BMTI) today introduced Augment™ as the new brand name for its portfolio of orthobiologic product candidates. This name replaces the GEM (Growth-factor Enhanced Matrix) family of trademarks, which was acquired by Luitpold Pharmaceuticals, Inc. in a transaction that divested the Company’s remaining dental business earlier this year.
